While headline pharmaceutical research and development (R&D) returns have improved for the third consecutive year, reaching a 7.0 percent internal rate of return (IRR) in 2025, this recovery is largely driven by a few mega-blockbuster programs, notably glucagon-like peptide receptor agonists (GLP-1s) and GLP-1 combinations with gastric inhibitory polypeptide-based drugs (GIPs) in obesity, masking broader R&D pressures
This is an over-the-counter product containing plant-based proteins, collagen peptides, fiber, prebiotics, probiotics, digestive enzymes, and essential nutrients
Gallensteine: Schnelle Gewichtsabnahme, unabhngig vom Wirkstoff, erhht generell das Risiko fr Gallensteinleiden
Regular intake of vitamin C improves the condition of the skin, increases the body's defenses, and supports the health of the mucous membranes